Freenome Stock
Multiomics Platform for Early Disease Screening
Sign up today and learn more about Freenome Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Freenome Stock
Headquartered in South San Francisco, Freenome is a health technology company developing accurate, accessible and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. Freenome aims to reinvent disease management through systematized early detection and intervention. Since launching in 2014, the company has raised more than $70 million from leading technology and healthcare investors.
Investors
Agent Capital
Allen & Company
Stripe, Relativity Space, Vroom, Joby Aviation, Convoy, Blend, Aspiration, Freenome, Turo, Bolt Threads
AME Cloud Ventures
Lacework, Wish, Eat Just, Zymergen, Illumio, Recursion Pharmaceuticals, Freenome, Astranis, FiscalNote, Planet
Andreessen Horowitz
Lyft, Robinhood, Databricks, Airbnb, Instacart, Stripe, Magic Leap, Anduril Industries, Rappi, CoinSwitch Kuber
Asset Management Ventures (AMV)
Bain Capital Life Sciences
BrightEdge Fund
Catalio Capital Management
Charles River Associates
Cormorant Asset Management
CRV
DoorDash, Airtable, Bird, Fair, Cybereason, Twitter, Niantic, ClassPass, Recursion Pharmaceuticals, Freenome
EcoR1 Capital
Fidelity Management and Research Company
goPuff, Nuro, Bolt, Caris Life Sciences, Relativity Space, Deliveroo, Farmers Business Network, Bowery Farming, Checkr, ASAPP
Founders Fund
Lyft, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass, Zenefits
GV
Uber, Robinhood, Jet, Impossible Foods, Lacework, Slack, Snyk, SambaNova Systems, DocuSign, Gusto
Innovation Endeavors
Plenty, Zymergen, Getaround, Freenome, Course Hero, Yotpo, HomeLight, Blockstream, fabric, Mark43
Janus Henderson Investors
Kaiser Permanente Ventures
Freenome, Proteus Digital Health, Vidyo, Everytable, Nuvolo, Ginger, Vesta Healthcare
Longevity Vision Fund
Loxbridge Research
Novartis
Perceptive Advisors
Zymergen, Freenome, Omada Health, Crossover Health, Twin Health, Emulate, PROCEPT BioRobotics, AEGEA Medical, Saama
Polaris Partners
Freenome, Automattic, Club Factory, Thirty Madison, OM1, Egnyte, Quartet, Impinj, VeraCode, Xant
Roche Venture Fund
Rock Springs Capital
S28 Capital
Collective Health, Freenome, Aurora Solar, Outschool, CaptivateIQ, Mattermost, Kespry
Sands Capital Management
Section 32
Celularity, Freenome, Dialpad, Lime, Metromile, Primer, Vineti, Kobalt, BigHat Biosciences
Third Kind Venture Capital
T. Rowe Price
One97, Flipkart, WeWork, Cruise, Airbnb, Rivian, Magic Leap, Nuro, Caris Life Sciences, Vroom
Verily
Funding History
| October 2015 | $800K |
|---|---|
| June 2016 | $5.6M |
| August 2017 | $72.0M |
| June 2019 | $165M |
| July 2020 | $270M |
Management
Chief Executive Officer
Mike Nolan
Chief Financial Officer
William Quirk
Press
businessinsider - Oct, 9 2023
Bluttests könnten die schlimmsten Krankheiten verhindern – diese Rolle spielen Startups dabeibioworld - May, 31 2023
Freenome buys immunodiagnostics company Oncimmune for $16Mfiercebiotech - May, 23 2023
Freenome puts down $16M to pick up fellow cancer test maker Oncimmunefinsmes - May, 22 2023
Freenome Acquires Oncimmunedlvr - May, 22 2023
Oncimmune Holdings sells businesses to Freenome in £13m dealgenomeweb - Apr, 15 2023
In Brief This Week: Mainz Biomed, Centogene, DermTech, Freenome, Ginkgo Biotech, Morebizjournals - Apr, 7 2023
CVS, liquid biopsy company Freenome teamed up for colorectal cancer studybiospace - Mar, 29 2023
Freenome Adds Renown Health as Partner for the Sanderson Studybiospace - Jan, 19 2023
Freenome Partners With Geisinger for the Sanderson Studynews - Dec, 19 2022
Funding Falls For Startups Fighting Cancernews - Oct, 17 2022
Stealth Biotech Startup Treeline Biosciences Raises $261Mhealthcareitnews - Sep, 8 2022
Freenome, working with Oracle Cerner network, launches multiomics oncology studygenomeweb - Jun, 5 2022
People in the News at Freenome, Quadrant Biosciences, Igentify, Morebiospace - Jun, 4 2022
Freenome Continues Growth, Adds Three New Leadersgenomeweb - Apr, 9 2022
People in the News: New Appointments at Freenome, Natera, Mission Bio, Moregeekwire - Apr, 4 2022
Tech Moves: Syndio hires managing director; Google travel vet returns to Expedia; ex-Adaptive CMO joins Freenomebizjournals - Apr, 1 2022
Real Estate Deals: Freenome's big lease highlights life science demandprnewswire - Jan, 24 2022
Freenome Presents Research Highlighting its Multiomics Blood Testing Platform in PREEMPT CRCnews - Jan, 14 2022
The Week’s 10 Biggest Funding Rounds: Project44 Nabs $420M To Help Supply Chain Issues, Bolt Checks Out With $355M and Biotech’s Big Weekmassdevice - Jan, 12 2022
Freenome raises $290M from Rochefiercebiotech - Jan, 12 2022
JPM22, Day 2: Freenome passes $1B funding mark; Amgen spices things up with Arrakis; Sage touts double-duty anxiety druglife-sciences-europe - Dec, 20 2021
Freenome–HBM: investment, 202112 financing round Series D totalling $300m incl new + co-investor HBM Healthcare Investmentsnews - Dec, 10 2021
The Week’s 10 Biggest Funding Rounds: YipitData Surpasses Unicorn Status, Claroty Locks Up Monster Round To Lockdown Industrial Cybersecurityfiercebiotech - Dec, 3 2021
Freenome, Siemens join forces to develop blood test for breast cancertheregister - Oct, 31 2021
Freenode IRC staff resign en masse, unhappy about new managementbiospace - Oct, 26 2021
Freenome Shows Continued Leadership in Colorectal Cancer Researchbuff - Oct, 6 2021
Freenome: Using Molecular Biology and Machine Learning to Detect Cancervcaonline - Aug, 28 2020
Venture Capital Database 2020 Now Available!chinamoneynetwork - Aug, 28 2020
Cancer Screening Startup Freenome Raises $270Mhubs - Aug, 28 2020
Freenome Raises $270 Million to Advance Colorectal Cancer Liquid Biopsyxconomy - Aug, 28 2020
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Earlybioworld - Aug, 28 2020
Freenome raises $270M in series C round for registration study of CRC liquid biopsy testnews - Aug, 26 2020
Freenome Secures $270M Series C To Research Cancer-Detecting Blood Testscnbc - Feb, 1 2020
These start-ups are racing to help doctors detect cancer early with a simple blood testnanalyze - Oct, 8 2019
9 Genomics Startups for Investors to Watchbioportfolio - Jul, 24 2019
Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detectionbusinesswire - Jul, 12 2018
Freenome’s IMPACT Advisory Board Brings Strategic Insight and Real-World Experience to AI-Genomics Cancer Testsbusinesswire - Apr, 24 2018
Freenome and Biognosys Announce Collaboration to Improve Early-Cancer Detection and Treatmentbusinesswire - Mar, 29 2018
Institut Curie and Freenome Announce a Strategic Collaboration in Cell-Free DNA Analysis Using Machine Learning Technologyxconomy - Mar, 22 2018
Freenome Co-founder & Investor Chat Where Big Data Meets Big Bio on April 26wired - Jan, 17 2018
Startups Race to Create Cancer Screens from DNAfiercebiotech - Dec, 11 2017
FreenomeTechCrunch - Jul, 8 2017
These South Bay and Peninsula cities are raking in venture capitalnanalyze - Apr, 18 2017
8 Blood Tests for Cancer Being Developed by StartupsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
